MN

Michael Nabil Michaeil Eskandar

Active Director Director DIN 10280498
DIN 10280498 First appointment Aug 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Michael Nabil Michaeil Eskandar

Data last updated:

Michael Nabil Michaeil Eskandar is a Director at Php For Pharmaceutical Industries Private Limited (since 2023). The company operates in Pharma.

DIN 10280498
Primary Designation Director
Industry Pharma
First Appointment 16 Aug 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Aug 20232023Active

Board colleagues of Michael Nabil Michaeil Eskandar

Directorship timeline

Open interactive timeline →
Php For Pharmaceutical Industries Private Limited
Premium access

Shareholding and investment profile for Michael Nabil Michaeil Eskandar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Michael Nabil Michaeil Eskandar

Michael Nabil Michaeil Eskandar currently holds 1 directorship: Php For Pharmaceutical Industries Private Limited (Director, since 16 Aug 2023).

Michael Nabil Michaeil Eskandar was first appointed on 16 Aug 2023 as Director at Php For Pharmaceutical Industries Private Limited.

The current boards of Michael Nabil Michaeil Eskandar's companies include Daya Shankar (Php For Pharmaceutical Industries Private Limited), Lena Nader Toma Attallah (Php For Pharmaceutical Industries Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available